Pancreatic Cancer

Clinical Challenge

• Mean survival is 6-12^1,2 months for the 80% of pts who are non-surgical candidates.
• Mean stent patency (metal): 72d³.
• Therefore, more than half of the patients may outlive the patency of their stents.
• Malignant biliary obstruction and cholangitis are the most commonly seen complication in patients suffering from pancreas tumors³.

Clinical Goal

Provide and maintain biliary decompression and drainage

Literature Highlights

Data is for Ablation + stenting vs stenting alone is mixed, depending upon the study.

• Mean SEMS Patency Improvement: 97.7%, 143+109 vs 72.3+37, p=0.01³
• Mean SEMS Patency 472d vs 374, p=0.669⁴ (statistically equivalent)